These are the stocks I observed and researched in May
Malaysian stocks:
$KGB (0151.MY)$ Long-term research, already hold positions, the earnings call for the next two quarters will be crucial
$KJTS (0293.MY)$ Needs further research, I believe the current stock price is too high
US stocks:
$Garmin (GRMN.US)$ -- Long-term research, wait for entry point
$Lemonade (LMND.US)$ -- Long-term research, already established low positions, high-risk investments, expecting very high returns
$monday.com (MNDY.US)$ Adding a new observation, bullish on higher explosiveness $Salesforce (CRM.US)$ , choose after weighing the pros and cons
Those kicked out of the observation list include
Malaysian stocks:
$EPMB (7773.MY)$ The recent surge of local autos companies indicates that the sector's risk is still very high, not worth taking the risk right now.
US stocks:
$Salesforce (CRM.US)$ -- Both in terms of positions and energy, there has already been too much investment in SaaS software stocks. After weighing the options, I choose $monday.com (MNDY.US)$
$CRISPR Therapeutics (CRSP.US)$ -- Medical stocks, or ETFs, are more practical choices.
Disclaimer: I am only sharing the stocks that I have focused on researching this month, and I do not provide any buying or selling recommendations. This is not financial advice.
Malaysian stocks:
$KGB (0151.MY)$ Long-term research, already hold positions, the earnings call for the next two quarters will be crucial
$KJTS (0293.MY)$ Needs further research, I believe the current stock price is too high
US stocks:
$Garmin (GRMN.US)$ -- Long-term research, wait for entry point
$Lemonade (LMND.US)$ -- Long-term research, already established low positions, high-risk investments, expecting very high returns
$monday.com (MNDY.US)$ Adding a new observation, bullish on higher explosiveness $Salesforce (CRM.US)$ , choose after weighing the pros and cons
Those kicked out of the observation list include
Malaysian stocks:
$EPMB (7773.MY)$ The recent surge of local autos companies indicates that the sector's risk is still very high, not worth taking the risk right now.
US stocks:
$Salesforce (CRM.US)$ -- Both in terms of positions and energy, there has already been too much investment in SaaS software stocks. After weighing the options, I choose $monday.com (MNDY.US)$
$CRISPR Therapeutics (CRSP.US)$ -- Medical stocks, or ETFs, are more practical choices.
Disclaimer: I am only sharing the stocks that I have focused on researching this month, and I do not provide any buying or selling recommendations. This is not financial advice.
Translated
13
5
FTSE Composite Index $FTSE Bursa Malaysia KLCI Index (.KLSE.MY)$ It broke through this year's intraday high this morning, and is also the highest since June 2022
If the market closes today and can hold 1,560 points, it will also record a new closing high since this year
Can horse-headed calves thrive and become big cows?
If the market closes today and can hold 1,560 points, it will also record a new closing high since this year
Can horse-headed calves thrive and become big cows?
Translated
These are the stocks I observed and researched in April.
Malaysian stocks:
$EPMB (7773.MY)$
$KGB (0151.MY)$
$KJTS (0293.MY)$
US stocks:
$Garmin (GRMN.US)$
$Salesforce (CRM.US)$
$Lemonade (LMND.US)$
$CRISPR Therapeutics (CRSP.US)$
Disclaimer: This is just a sharing of the stocks I have focused on researching this month and does not constitute any buy or sell recommendations. This is not my holdings and not my complete watchlist.
Malaysian stocks:
$EPMB (7773.MY)$
$KGB (0151.MY)$
$KJTS (0293.MY)$
US stocks:
$Garmin (GRMN.US)$
$Salesforce (CRM.US)$
$Lemonade (LMND.US)$
$CRISPR Therapeutics (CRSP.US)$
Disclaimer: This is just a sharing of the stocks I have focused on researching this month and does not constitute any buy or sell recommendations. This is not my holdings and not my complete watchlist.
Translated
5